These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease. Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874 [No Abstract] [Full Text] [Related]
14. Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. Hegerl U; Mergl R; Henkel V; Gallinat J; Kotter G; Müller-Siecheneder F; Pogarell O; Juckel G; Schröter A; Bahra R; Emir B; Laux G; Möller HJ J Clin Psychopharmacol; 2003 Apr; 23(2):214-6. PubMed ID: 12640228 [No Abstract] [Full Text] [Related]
15. Aggressive behaviour associated with donepezil treatment: a case report. Bianchetti A; Trabucchi M; Cipriani G Int J Geriatr Psychiatry; 2003 Jul; 18(7):657-8. PubMed ID: 12833312 [No Abstract] [Full Text] [Related]
17. Neuroleptic malignant-like syndrome due to donepezil and maprotiline. Ohkoshi N; Satoh D; Nishi M; Shoji S Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986 [No Abstract] [Full Text] [Related]
18. Cholinesterase inhibitor treatment and urinary incontinence in Alzheimer's disease. Starr JM J Am Geriatr Soc; 2007 May; 55(5):800-1. PubMed ID: 17493206 [No Abstract] [Full Text] [Related]
19. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study. Prasher VP; Adams C; Holder R; Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681 [No Abstract] [Full Text] [Related]